Skip to main content

Table 3 Comparison of primary tumor and metastatic tissue by HER2 status (PRIM-HER2 and MET-HER2 status, respectively)

From: The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

 

Total

MET-HER2-negative

MET-HER2-positive

PRIM-HER2 status (total)

46 (100 %)

40/46 (87 %)

6/46 (13 %)

 Negative

42/46 (91 %)

37/42 (88 %)

5/42 (12 %)

 Positive

4/46 (9 %)

3/4 (7 %)

1/4 (25 %)

  1. Overall accuracy of MET-HER2 and PRIM-HER2 status: 83 %
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us